Mitochondrial dysfunction is the major mechanism precipitating I/R injury which commonly occurs during liver surgery, trauma, hemorrhagic shock and liver transplantation. Sirtuin 1 (SIRT1) is an NAD+-dependent deacetylase that induces longevity, stress resistance and tumor suppression. The role of SIRT1 in ischemia/reperfusion-mediated liver injury is unknown. The goal of this study is to investigate the role of SIRT1 in I/R injury to liver and to develop therapeutic strategies to improve liver function after I/R. Our principal hypothesis is that calpain-dependent SIRT1 loss causes a sequential chain of defective mitophagy, mitochondrial permeability transition (MPT) onset and hepatocyte death after I/R. Accordingly, we propose that restoration or enhancement of hepatic SIRT1 will promote mitophagy and consequently ameliorate mitochondrial failure and liver dysfunction after reperfusion. To test our hypothesis, we will use hepatocytes isolated from SIRT1 wild type (WT) and knockout (KO) mice for characterization of cellular mechanisms causing SIRT1 depletion, defective mitophagy, and onset of the MPT and cell death after I/R. In addition, we will use anesthetized WT and KO SIRT1 mice to confirm and extend our in vitro findings to an in vivo model of hepatic I/R. Finally, we will extend and translate our findings from mice into human liver biopsies. These studies provide critical mechanistic insights into lethal I/R injury to the lver, and will establish novel therapeutic approaches for improving I/R-mediated liver failure.
Impairment of blood flow causes a tissue ischemia and recovery of blood flow causes reperfusion injury to liver. Ischemia/reperfusion (I/R) injury is a causative factor of morbidity and mortality during liver resection, hemorrhagic shock, trauma, and transplantation. I/R injury remains a fundamental complication of hepatic surgery, and patients with preexisting liver diseases that often require inflow occlusion are more likely to develop severe postoperative I/R injury. Better understanding of the mechanisms underlying ischemia/reperfusion injury would establish novel therapeutic approaches for improving liver function after liver surgery.
|Biel, T G; Lee, S; Flores-Toro, J A et al. (2016) Sirtuin 1 suppresses mitochondrial dysfunction of ischemic mouse livers in a mitofusin 2-dependent manner. Cell Death Differ 23:279-90|
|Sooyeon, Lee; Go, Kristina L; Kim, Jae-Sung (2016) Deacetylation of mitofusin-2 by sirtuin-1: A critical event in cell survival after ischemia. Mol Cell Oncol 3:e1087452|
|Law, Mary E; Ferreira, Renan B; Davis, Bradley J et al. (2016) CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment. Breast Cancer Res 18:80|
|Chun, Sung Kook; Go, Kristina; Yang, Ming-Jim et al. (2016) Autophagy in Ischemic Livers: A Critical Role of Sirtuin 1/Mitofusin 2 Axis in Autophagy Induction. Toxicol Res 32:35-46|
|(2016) Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12:1-222|
|Flores-Toro, Joseph A; Go, Kristina L; Leeuwenburgh, Christiaan et al. (2016) Autophagy in the liver: cell's cannibalism and beyond. Arch Pharm Res 39:1050-61|
|Vlada, Claudiu A; Kim, Jae-Sung; Behrns, Kevin E (2015) Autophagy: self-preservation through cannibalism of proteins and organelles. Surgery 157:1-5|
|Cho, J; Seo, J; Lim, C H et al. (2015) Mitochondrial ATP transporter Ant2 depletion impairs erythropoiesis and B lymphopoiesis. Cell Death Differ 22:1437-50|
|Vairetti, Mariapia; Jaeschke, Hartmut; Monbaliu, Diethard et al. (2015) Innovative Pharmacological/Therapeutic Approaches against Hepatic Ischemia/Reperfusion Injury. Biomed Res Int 2015:918583|
|Jenkitkasemwong, Supak; Wang, Chia-Yu; Coffey, Richard et al. (2015) SLC39A14 Is Required for the Development of Hepatocellular Iron Overload in Murine Models of Hereditary Hemochromatosis. Cell Metab 22:138-50|
Showing the most recent 10 out of 27 publications